TY - JOUR
T1 - Genetic variation and recurrent haplotypes on chromosome 6q23-25 risk locus in familial lung cancer
AU - Musolf, Anthony M.
AU - Simpson, Claire L.
AU - Moiz, Bilal A.
AU - Pikielny, Claudio W.
AU - Middlebrooks, Candace D.
AU - Mandal, Diptasri
AU - De Andrade, Mariza
AU - Cole, Michael D.
AU - Gaba, Colette
AU - Yang, Ping
AU - You, Ming
AU - Li, Yafang
AU - Kupert, Elena Y.
AU - Anderson, Marshall W.
AU - Schwartz, Ann G.
AU - Pinney, Susan M.
AU - Amos, Christopher I.
AU - Bailey-Wilson, Joan E.
N1 - Funding Information:
C.L. Simpson reports grants from National Lung Cancer Partnership during the conduct of the study. M. You reports grants from NIH during the conduct of the study and other support from OncoC4, Inc. and OncoImmune, Inc. outside the submitted work. A.G. Schwartz reports grants from NIH during the conduct of the study. S.M. Pinney reports grants from NIH/NCI during the conduct of the study. C.I. Amos reports grants from NCI and Cancer Prevention Research Institute of Texas during the conduct of the study. J.E. Bailey-Wilson reports grants from National Lung Cancer Partnership during the conduct of the study. No disclosures were reported by the other authors.
Funding Information:
The authors thank all study participants and their families. This work was funded in part by the NIH, NCI grants U01CA76293 (S.M. Pinney and M.W. Anderson), U01CA243483 (C.I. Amos and S.M. Pinney), P50CA125123 (C.I. Amos), P30CA22453 (A.G. Schwartz), R03CA77118 (P. Yang), R01CA80127 (P. Yang), and R01CA84354 (P. Yang), National Institutes of Health, National Institute of Environmental Health Sciences P30ES006096 (S.M. Pinney); and Department of Health and Human Services contracts HHSN26820100007C (D. Mandal), HHSN268201700012C (D. Mandal), and HHSN75N92020C00001 (D. Mandal). C.I. Amos is a Research Scholar of the Cancer Prevention Research Institute of Texas (CPRIT). This research was partially supported by CPRIT grant RR170048. J.E. Bailey-Wilson, A.M. Musolf, B.A. Moiz, C.D. Middlebrooks, and C.L. Simpson were funded in part by the Intramural Research Program of the National Human Genome Research Institute, NIH. P. Yang and M. de Andrade were funded in part by the Mayo Foundation Fund. This work was funded in part by the National Lung Cancer Partnership (now Free to Breathe) Young Investigator Research Grant to C.L. Simpson. The GTEx Project was supported by the Common Fund of the Office of the Director of the NIH and by NCI, National Human Genome Research Institute, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health, and National Institute of Neurological Disorders and Stroke. The data used in this study were obtained from the GTEx portal on April 17, 2020. This work utilized the computational resources of the NIH HPC Biowulf cluster (http://hpc.nih.gov).
Funding Information:
The authors thank all study participants and their families. This work was funded in part by the NIH, NCI grants U01CA76293 (S.M. Pinney and M.W. Anderson), U01CA243483 (C.I. Amos and S.M. Pinney), P50CA125123 (C.I. Amos), P30CA22453 (A.G. Schwartz), R03CA77118 (P. Yang), R01CA80127 (P. Yang), and R01CA84354 (P. Yang), National Institutes of Health, National Institute of Environmental Health Sciences P30ES006096 (S.M. Pinney); and Department
Publisher Copyright:
© 2021 American Association for Cancer Research.
PY - 2021/6
Y1 - 2021/6
N2 - Although lung cancer is known to be caused by environmental factors, it has also been shown to have genetic components, and the genetic etiology of lung cancer remains understudied. We previously identified a lung cancer risk locus on 6q23-25 using microsatellite data in families with a history of lung cancer. To further elucidate that signal, we performed targeted sequencing on nine of our most strongly linked families. Two-point linkage analysis of the sequencing data revealed that the signal was heterogeneous and that different families likely had different risk variants. Three specific haplotypes were shared by some of the families: 6q25.3-26 in families 42 and 44, 6q25.2-25.3 in families 47 and 59, and 6q24.2-25.1 in families 30, 33, and 35. Region-based logarithm of the odds scores and expression data identified the likely candidate genes for each haplotype overlap: ARID1B at 6q25.3, MAP3K4 at 6q26, and UTRN (6q24.1) and PHACTR2 (6q24.2). Further annotation was used to zero in on potential risk variants in those genes. All four genes are good candidate genes for lung cancer risk, having been linked to either lung cancer specifically or other cancers. However, this is the first time any of these genes has been implicated in germline risk. Functional analysis of these four genes is planned for future work.
AB - Although lung cancer is known to be caused by environmental factors, it has also been shown to have genetic components, and the genetic etiology of lung cancer remains understudied. We previously identified a lung cancer risk locus on 6q23-25 using microsatellite data in families with a history of lung cancer. To further elucidate that signal, we performed targeted sequencing on nine of our most strongly linked families. Two-point linkage analysis of the sequencing data revealed that the signal was heterogeneous and that different families likely had different risk variants. Three specific haplotypes were shared by some of the families: 6q25.3-26 in families 42 and 44, 6q25.2-25.3 in families 47 and 59, and 6q24.2-25.1 in families 30, 33, and 35. Region-based logarithm of the odds scores and expression data identified the likely candidate genes for each haplotype overlap: ARID1B at 6q25.3, MAP3K4 at 6q26, and UTRN (6q24.1) and PHACTR2 (6q24.2). Further annotation was used to zero in on potential risk variants in those genes. All four genes are good candidate genes for lung cancer risk, having been linked to either lung cancer specifically or other cancers. However, this is the first time any of these genes has been implicated in germline risk. Functional analysis of these four genes is planned for future work.
UR - http://www.scopus.com/inward/record.url?scp=85108097814&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85108097814&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-20-3196
DO - 10.1158/0008-5472.CAN-20-3196
M3 - Article
C2 - 33853833
AN - SCOPUS:85108097814
SN - 0008-5472
VL - 81
SP - 3162
EP - 3173
JO - Cancer research
JF - Cancer research
IS - 12
ER -